Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehr

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
Modeling the meta-dynamics of lymphocyte repertoiresR Mehr
American Health & Drug Benefits|April 12, 2016
Payer Perspectives on PCSK9 Inhibitors: A Conversation with Stephen Gorshow, MD, and James T. Kenney, RPh, MBAStanton R Mehr
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Will the emerging private-label market access channel help or hinder biosimilar market access?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Sustaining competition for biosimilars on the pharmacy benefit: Use it or lose itStanton R Mehr
Managed Care Interface|February 4, 2006
The evolutionary role of the pharmacy and therapeutics committee in technology assessmentStanton R Mehr
American Health & Drug Benefits|September 9, 2016
Will the PCSK9 Inhibitors Be Employers' "Line in the Sand"?Stanton R Mehr
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Reconciling repertoire shift with affinity maturation: the role of deleterious mutationsM Shannon, R Mehr
Bio Systems|January 1, 1992
Bone marrow regeneration under cytotoxic drug regimens: behaviour ranging from homeostasis to unpredictability in a model for hemopoietic differentiationR Mehr, Z Agur
Parasite Immunology|April 1, 1997
Modelling Trypanosoma congolense parasitaemia patterns during the chronic phase of infection in N'Dama cattleZ Agur, R Mehr
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1997
Blind T-cell homeostasis and the CD4/CD8 ratio in the thymus and peripheral bloodR Mehr, A S Perelson
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Archivum Immunologiae Et Therapiae Experimentalis|May 12, 2001
Modeling the meta-dynamics of lymphocyte repertoiresR Mehr
American Health & Drug Benefits|April 12, 2016
Payer Perspectives on PCSK9 Inhibitors: A Conversation with Stephen Gorshow, MD, and James T. Kenney, RPh, MBAStanton R Mehr
Journal of Managed Care & Specialty Pharmacy|July 24, 2025
Will the emerging private-label market access channel help or hinder biosimilar market access?Stanton R Mehr
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Sustaining competition for biosimilars on the pharmacy benefit: Use it or lose itStanton R Mehr
Managed Care Interface|February 4, 2006
The evolutionary role of the pharmacy and therapeutics committee in technology assessmentStanton R Mehr
American Health & Drug Benefits|September 9, 2016
Will the PCSK9 Inhibitors Be Employers' "Line in the Sand"?Stanton R Mehr
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
Reconciling repertoire shift with affinity maturation: the role of deleterious mutationsM Shannon, R Mehr
Bio Systems|January 1, 1992
Bone marrow regeneration under cytotoxic drug regimens: behaviour ranging from homeostasis to unpredictability in a model for hemopoietic differentiationR Mehr, Z Agur
Parasite Immunology|April 1, 1997
Modelling Trypanosoma congolense parasitaemia patterns during the chronic phase of infection in N'Dama cattleZ Agur, R Mehr
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 15, 1997
Blind T-cell homeostasis and the CD4/CD8 ratio in the thymus and peripheral bloodR Mehr, A S Perelson
Pageof 17